Results 231 to 240 of about 19,404,997 (303)

Characterizing Biopolymer Electrolytes in Zinc–Air Batteries: Challenges, Best Practices, and a Robust Workflow Guiding Future Research Paths

Advanced Energy Materials, EarlyView.
Bio‐based gel polymer electrolytes promise sustainable, mechanically adaptable zinc–air batteries, yet their progress is constrained by inconsistent characterization. This review critically links formulation, structure, interfaces, and cell performance, identifies methodological gaps under alkaline operating conditions, and proposes application ...
Matteo Milanesi, Hiba Ali, Barbara Belza, Mattia F. Palermo, Claudio Gerbaldi, Giuseppe Antonio Elia, Nagore Ortiz‐Vitoriano   +6 more
wiley   +1 more source

Faunal Deposits in Pre-Beaker Funerary Contexts at Humanejos (Parla, Madrid, Spain). [PDF]

Animals (Basel)
Estaca-Gómez V, Aguilar-Molina L, Herrero-Corral AM, Paulos-Bravo R, Maicas R, Flores-Fernández R, Garrido-Pena R, Yravedra J.   +7 more
europepmc   +1 more source

Real-world treatment patterns and outcomes in moderate-to-severe SLE: findings from the Spanish SPOCS cohort. [PDF]

Lupus Sci Med
Lozano-Rivas N, Rúa-Figueroa I, Freire-González M, Turrión A, Castellvi I, Barbado Ajo J, Calvo-Alén J, Ortego-Centeno N, Díaz-Encarnación M, Pego-Reigosa JM, Ding B, Galvez-Fernandez M, Bahamontes-Rosa N, Cervera R, Spanish SLE Prospective Observational Cohort Study (SPOCS).   +14 more
europepmc   +1 more source

Correction to "Differential peritoneal resident macrophage depletion and omental milky spot disruption after high versus low clodronate-loaded liposome dose treatment". [PDF]

Immunol Cell Biol
europepmc   +1 more source

Correction: Analysis of glycaemic control with a connected smart pen cap in adults with type 1 diabetes: a randomised, open-label, parallel-group trial. [PDF]

Diabetologia
Sebastian-Valles F, Sager-La Ganga C, Enriquez AJ, Blanco SJ, Navas-Moreno V, Arranz Martin JA, Marazuela M.   +6 more
europepmc   +1 more source

Sudden re-emergence of <i>Streptococcus pyogenes</i> subtype <i>emm</i>3.93 in Spain, 2023-2024. [PDF]

New Microbes New Infect
Pilar V, María José MP, Noelia G, Mónica V, Sara M, Sarai V, Sylvia V.   +6 more
europepmc   +1 more source

Long-Term Outcomes in Patients With Recurrent Ovarian Cancer and Exceptional Response to PARP Inhibitors.

JAMA Oncol
Haggstrom L, Lee YC, Barretina-Ginesta MP, Jaeger A, Woelber L, Woopen H, Rhind M, Frenel JS, Aanum A, Bischof K, Mongillo M, Brodsky AL, Ledermann J, Ghezelayagh TS, Boere I, Kaiser S, Maximiano C, Rosengarten O, Safra T, Pertejo A, Cecere S, Ray-Coquard I, Lheureux S, Glasspool R, Gil-Martin M, Tookman L, Kim SI, Mittelstadt S, Corbellas Aparicio M, Palacio I, Martin-Lorente C, Kristeleit R, de la Cueva H, Ottevanger N, Quindós Varela M, Yoshida H, Link T, Gaba L, Marquina G, Burdett N, Johannet P, Reichenbach J, Park-Simon TW, Klecker PH, González-Martín A, Marth C, Liebrich C, Dzotsenidze L, Heublein S, Kasherman L, Perez C, Masvidal M, Guillén Sentís P, de Gregorio N, Hemptenmacher F, Hilpert F, Sehouli J, Scott C, Tucker KM, Dong J, Fortuno C, Spurdle AB, Friedlander M, Gynecologic Cancer InterGroup Collaboration Into Exceptional Responders to PARP Inhibitors (GCIG-CERP).   +63 more
europepmc   +1 more source

[Smallpox in New Spain].

Gaceta medica de Mexico, 1998
openaire   +1 more source